Test Bank For Nurse Practitioner Certification Examinationand Practice Preparation, 5th Edition Margaret A. Fitzgerald

Section 1: Health Promotion & Disease Prevention 1. An example of a primary prevention measure for a 78-yo male with chronic pulmonary disease is: A. reviewing the use of prescribed medications. B. conducting a home survey to minimize fall risk. C. checking FEV1 to FVC ratio. D. ordering fecal occult blood. 2. Which of the following is an example of a primary prevention activity in a 76-yo woman with osteoporosis? A. bisphosphonate therapy. B. calcium supplements. C. ensuring adequate illumination in the home. D. use of a back brace. 3. Secondary prevention measures for a 78-yo male with chronic obstructive pulmonary disease includes: A. screening for mood disorders. B. administering influenza vaccine. C. obtaining a serum theophylline level. D. advising about appropriate use of a seat belt. 4. Tertiary prevention measures for a 69-yo woman with heart failure include: A. administering pneumococcal vaccine. B. adjusting therapy to minimize dyspnea. C. surveying skin for precancerous lesions. D. reviewing safe handling of food. 5. Which of the following products provides passive immunity? A. hepatitis B immune globulin. B. measles, mumps, & rubella vaccine. C. pneumococcal conjugate vaccine. D. live attenuated influenza vaccine. 6. Active immunity is defined as: A. resistance developed in response to an antigen. B. immunity conferred by an antibody. C. the resistance of a group to an infectious agent. D. defense against disease acquired naturally by the infant from the mother. 7. Which of the following is usually viewed as the most cost-effective form of healthcare? A. primary prevention. B. secondary prevention. C. tertiary prevention. D. cancer-reduction measures. 8. An 18-yo woman with allergic rhinitis presents for primary care. She is sexually active with a male partner and is one-year post-coitarche; during the time she had two sex partners. An example of a primary prevention activity for this patient is: A. screening for STI. B. counseling about safe sex practices. C. prescribing therapies for minimizing allergy. D. obtaining a liquid based Papanicolaou test. 9. When a critical portion of a population is immunized against a contagious disease, most members of the group, even the unimmunized, are protected against that disease because there is little opportunity for an outbreak. This is known as what type of immunity? A. passive. B. humoral. C. epidemiologic. D. community. Section 2: Influenza Immunization 10. When advising a patient about injectable influenza immunization, the nurse practitioner considers the following about the use of this vaccine: A. its use is not recommended in sickle cell anemia. B. its use is limited to children older than 2 years. C. its use is limited because it contains live virus. D. its use is recommended for virtually all members of the population. 11. A middle-aged man with chronic obstructive pulmonary disease who is about to receive injectable influenza vaccine should be advised that: A. it is more than 90% effective in preventing influenza. B. its use is contraindicated in the presence of psoriasis vulgaris. C. localized reactions such as soreness & redness at the site are fairly common. D. a short, intense, flu-like syndrome typically occurs after immunization. 12. A 44-yo woman with asthma presents asking for the “flu shot”. She is seen today for an urgent care visit, is diagnosed with a lower urinary tract infection and prescribed trimethoprim-sulfamethoxale. She is without fever or GI upset with stable respiratory status. You inform her that she: A. should return for the immunization after completing her antibiotic therapy. B. would likely develop a significant reaction if immunized today. C. can receive the immunization today. D is not a candidate for any form of influenza vaccine. 13. Which of the following statements best describes amantadine or rimantadine use in the care of patients with or at risk for influenza? A. significant resistance to select strains of influenza limits the usefulness of these meds B. the primary action of these therapies is in preventing influenza A during outbreaks. C. these therapies are active against influenza A & B. D. the use of these products is an acceptable alternative to influenza vaccine. 14. Which of the following statements best describes zanamivir (Relenza) or oseltamivir (Tamiflu) use in the care of patients with or at risk for influenza? A. initiation of therapy early in acute influenza illness can help minimize the severity of disease when the illness is caused by a nonresistant viral strain. B. the primary indication is in preventing influenza A during outbreaks. C. the drugs are active only against influenza B. D. the use of these medications is an acceptable alternative to influenza vaccine. 15. When advising a patient about the influenza nasal spray vaccine, the NP considers the following: A. its use is acceptable during pregnancy. B. its use is limited to children younger than 6. C. it contains live, attenuated virus. D. this is the preferred method of influenza protection in the presence of airway disease 16. Approximately of healthcare providers receive influenza immunization annually. A. one-quarter. B. one-half. C. two-thirds. D. three-quarters or more. 17. The most common mode of influenza virus transmission is via: A. contact with a contaminated surface. B. respiratory droplet. C.saliva contact. D. skin-skin contact. 18. In an immunocompetent adult, the length of incubation for the influenza virus is on average: A. less than 24 hours. B. 1-4 days. C. 4-7 days. D. more than 1 week. 19. Influenza protection options for a 62-yo man with hypertension, dyslipidemia and type 2 diabetes mellitus include receiving: A. live attenuated influenza vaccine via nasal spray. B. high-dose trivalent inactivated vaccine (TIV) via intramuscular injection. C. TIV in standard dose via intramuscular injection. D. appropriate antiviral medication at the initial onset of influenza-like illness. 20. Which of the following should not receive vaccination against influenza? A. a 19-yo with a history of hive-form reaction to eating eggs. B. a 24-yo woman who is 8 weeks pregnant. C. a 4-month old who was born at 32-weeks. D. a 28-yo woman who is breastfeeding.